Tango Therapeutics, Inc. - Common Stock (TNGX)

CUSIP: 87583X109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
135,353,744
Total 13F shares
69,679,958
Share change
+1,904,808
Total reported value
$528,174,476
Price per share
$7.58
Number of holders
70
Value change
+$13,385,662
Number of buys
41
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 87583X109?
CUSIP 87583X109 identifies TNGX - Tango Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q1 2022

As of 31 Mar 2022, Tango Therapeutics, Inc. - Common Stock (TNGX) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,679,958 shares. The largest 10 holders included TRV GP IV, LLC, FMR LLC, BOXER CAPITAL, LLC, Casdin Capital, LLC, Cormorant Asset Management, LP, Southpoint Capital Advisors LP, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, and Avoro Capital Advisors LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.